158 related articles for article (PubMed ID: 32429914)
1. Ion-Channel modulator TH1177 reduces glomerular injury and serum creatinine in chronic mesangial proliferative disease in rats.
Cove-Smith A; Sharpe CC; Shattock MJ; Hendry BM
BMC Nephrol; 2020 May; 21(1):187. PubMed ID: 32429914
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis.
Cove-Smith A; Mulgrew CJ; Rudyk O; Dutt N; McLatchie LM; Shattock MJ; Hendry BM
Am J Pathol; 2013 Aug; 183(2):391-401. PubMed ID: 23746655
[TBL] [Abstract][Full Text] [Related]
3. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
4. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
6. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
Masuda Y; Shimizu A; Kataoka M; Arai T; Ishikawa A; Du X; Saito SK; Aki K; Nagasaka S; Mii A; Fujita E; Fukuda Y
Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
[TBL] [Abstract][Full Text] [Related]
10. Glomerular damage in experimental proliferative glomerulonephritis under glomerular capillary hypertension.
Wang PR; Kitamura H; Shimizu A; Yamanaka N
Kidney Blood Press Res; 2015; 40(2):188-99. PubMed ID: 25871528
[TBL] [Abstract][Full Text] [Related]
11. Stimulated phosphorylation of ERK in mouse kidney mesangial cells is dependent upon expression of Cav3.1.
Pandi SPS; Shattock MJ; Hendry BM; Sharpe CC
BMC Nephrol; 2022 Jun; 23(1):211. PubMed ID: 35710406
[TBL] [Abstract][Full Text] [Related]
12. The leukotriene B4 receptor antagonist ONO-4057 inhibits mesangioproliferative changes in anti-Thy-1 nephritis.
Kawasaki Y; Tanji M; Takano K; Fukuda Y; Isome M; Nozawa R; Suzuki H; Hosoya M
Nephrol Dial Transplant; 2005 Dec; 20(12):2697-703. PubMed ID: 16221713
[TBL] [Abstract][Full Text] [Related]
13. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T; Oka M; Maesato K; Mano T; Ikee R; Moriya H; Kobayashi S
Hypertens Res; 2008 Mar; 31(3):387-94. PubMed ID: 18497456
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
15. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis.
Schaier M; Lehrke I; Schade K; Morath C; Shimizu F; Kawachi H; Grone HJ; Ritz E; Wagner J
Kidney Int; 2001 Dec; 60(6):2222-34. PubMed ID: 11737596
[TBL] [Abstract][Full Text] [Related]
17. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Nephron; 1998; 79(2):206-14. PubMed ID: 9647502
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid reduces glomerular injury in a rat model of glomerular damage.
Wagner J; Dechow C; Morath C; Lehrke I; Amann K; Waldherr R; Floege J; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1479-1487. PubMed ID: 10906161
[TBL] [Abstract][Full Text] [Related]
19. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]